"Independent pharmacy providing traditional retail and specialty compounded prescriptions."

During the past decade, Foers Medical Arts Pharmacy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Foers Medical Arts Pharmacy" #1 collaborator was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Foers Medical Arts Pharmacy" are "Alzheimer's Disease" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Foers Medical Arts Pharmacy" in a lesser frequency.

Most popular intervention types in "Foers Medical Arts Pharmacy" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AAB-003 (PF-05236812)" (2 trials), "Placebo" (1 trials), "bapineuzumab" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Foers Medical Arts Pharmacy" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Foers Medical Arts Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Foers Medical Arts Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Foers Medical Arts Pharmacy, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".